Patents by Inventor Jörg Schneider

Jörg Schneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8044197
    Abstract: Radiation-curable 1,3,5-triazine carbamates and 1,3,5-triazine ureas, processes for preparing them and their use.
    Type: Grant
    Filed: April 8, 2005
    Date of Patent: October 25, 2011
    Assignee: BASF SE
    Inventors: Yvonne Heischkel, Joerg Schneider, Reinhold Schwalm, Guenter Scherr
  • Patent number: 8034929
    Abstract: The invention relates to a process for preparing polymethylolated melamine and polymethylolated melamine compounds polyetherified with alkanol, wherein the methylolation reaction is carried out in a kneading reactor.
    Type: Grant
    Filed: January 13, 2005
    Date of Patent: October 11, 2011
    Assignee: BASF SE
    Inventors: Jörg Schneider, Günter Scherr, Rainer Erhardt, Andreas Eichfelder, Martin Reif, Stefan Hirsch, Hans Schupp, Christel Hittinger, Alain Robert
  • Patent number: 8030485
    Abstract: The invention relates to a process for preparing free-flowing, pulverulent alkoxycarbonylaminotriazine from an alkanolic reaction mixture which is obtained in the preparation of alkoxycarbonylaminotriazines and comprises at least one alkoxycarbonylaminotriazine, at least one cyclic and/or acyclic carbonic ester, at least one C1-C13-alkanol which optionally comprises one or two oxygen atoms in the form of ether bonds and is optionally substituted by C1-C4-alkyl and/or hydroxyl, and also at least one alkali metal or alkaline earth metal alkoxide, with or without melamine and with or without catalyst, by atomizing and drying the reaction mixture in a spray drier.
    Type: Grant
    Filed: May 31, 2006
    Date of Patent: October 4, 2011
    Assignee: BASF Aktiengesellschaft
    Inventors: Joerg Schneider, Guenter Scherr, Rainer Erhardt, Andreas Eichfelder, Martin Reif, Stefan Hirsch, Georg Sieder, Thomas Holtmann, Juergen Ciprian, Hermann Ascherl
  • Publication number: 20110197909
    Abstract: The present invention concerns a composition for the permanent shaping of human hair used both for the permanent waving of human hair with an excellent waving effect as well as for the straightening of either naturally or chemically curled hair comprising a diamide compound. Accordingly, the present invention is on a composition for permanent shaping hair based on at least one reducing agent and a compound comprising at least two amide (diamide) groups in its molecule and at least one cationic polymer. Preferred diamide compounds are according to the general structure wherein R1 is a linear or branched, saturated or unsaturated alkyl chain with 1 to 12 C atoms which may be substituted with hydroxy and/or alkoxy groups, R2 is linear or branched alkyl chain with 1 to 5 C atoms, and R3 linear or branched, saturated or unsaturated alkyl chain with 1 to 22 C atoms.
    Type: Application
    Filed: October 20, 2009
    Publication date: August 18, 2011
    Inventors: Jonathan Wood, Alexandra Hullmann, Jörg Schneider
  • Publication number: 20110159034
    Abstract: New methods and reagents for vaccination are described which generate a CD8 T cell immune response against malarial and other antigens such as viral and tumour antigens. Novel vaccination regimes are described which employ a priming composition and a boosting composition, the boosting composition comprising a non-replicating or replication-impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition.
    Type: Application
    Filed: November 5, 2010
    Publication date: June 30, 2011
    Inventors: Andrew McMICHAEL, Adrian V.S. Hill, Sarah C. Gilbert, Jörg Schneider, Magdalena Plebanski, Tomas Hanke, Geoffrey L. Smith, Tom Blanchard
  • Publication number: 20110044926
    Abstract: The present invention concerns a composition for the permanent shaping of human hair used both for the permanent waving of human hair with an excellent waving effect as well as for the straightening of curled hair comprising at least one ubichinone of the formula where n is a number between 1 and 10 at a concentration of 0.0001 to 1% by weight calculated to total composition.
    Type: Application
    Filed: November 4, 2010
    Publication date: February 24, 2011
    Applicant: KPSS-Kao Professional Salon Services GmbH
    Inventors: Jonathan WOOD, Bernd Nöcker, Sandra Schmelz, Britta Punsch, Jörg Schneider
  • Patent number: 7850953
    Abstract: The present invention concerns a composition for the permanent shaping of human hair used both for the permanent waving of human hair with an excellent waving effect as well as for the straightening of curled hair comprising at least one ubichinone of the formula where n is a number between 1 and 10 at a concentration of 0.0001 to 1% by weight calculated to total composition.
    Type: Grant
    Filed: December 6, 2006
    Date of Patent: December 14, 2010
    Assignee: KPSS-Kao Professional Salon Services GmbH
    Inventors: Jonathan Wood, Bernd Noecker, Sandra Schmelz, Britta Punsch, Joerg Schneider
  • Publication number: 20100181564
    Abstract: The invention relates to a printable precursor comprising an organometallic zinc complex which contains at least one ligand from the class of the oximates and is free from alkali metals and alkaline-earth metals, for electronic components and to a preparation process. The invention furthermore relates to corresponding printed electronic components, preferably field-effect transistors.
    Type: Application
    Filed: June 17, 2008
    Publication date: July 22, 2010
    Applicant: MERCK PATENT GESELLSCHAFT MIT6 BESCHRANKTER HAFT
    Inventors: Ralf Kuegler, Joerg Schneider, Rudolf Hoffmann
  • Publication number: 20100113693
    Abstract: The invention relates to a process for preparing polymethylolated melamine and polymethylolated melamine compounds polyetherified with alkanol, wherein the methylolation reaction is carried out in a kneading reactor.
    Type: Application
    Filed: January 13, 2005
    Publication date: May 6, 2010
    Applicant: BASF Aktiengesellschaft
    Inventors: Jörg Schneider, Günter Scherr, Rainer Erhardt, Andreas Eichfelder, Martin Reif, Stefan Hirsch, Hans Schupp, Christel Hittinger, Alain Robert
  • Patent number: 7517474
    Abstract: New triazine derivatives containing carbamate groups, processes for preparing them, and their use.
    Type: Grant
    Filed: April 8, 2005
    Date of Patent: April 14, 2009
    Assignee: BASF Aktiengesellschaft
    Inventors: Eva Wagner, Reinhold Schwalm, Joerg Schneider, Rainer Erhardt, Carl Jokisch, Heinz-Peter Rink
  • Patent number: 7514087
    Abstract: New methods and reagents for vaccination are described which generate a CD8 T cell immune response against malarial and other antigens such as viral and tumor antigens. Novel vaccination regimes are described which employ a priming composition and a boosting composition, the boosting composition comprising a non-replicating or replication-impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition.
    Type: Grant
    Filed: April 28, 2004
    Date of Patent: April 7, 2009
    Assignee: Oxxon Therapeutics Limited
    Inventors: Andrew McMichael, Adrian V. S. Hill, Sarah C. Gilbert, Jörg Schneider, Magdalena Plebanski, Tomas Hanke, Geoffrey L. Smith, Tom Blanchard
  • Patent number: 7507818
    Abstract: In a process for preparing alkoxycarbonylaminotriazines, di- or triaminotriazines are reacted with cyclic carbonic esters and optionally with minor amounts of acyclic carbonic esters in the presence of an alcohol and of an alkali metal alkoxide or alkaline earth metal alkoxide as a base.
    Type: Grant
    Filed: December 16, 2003
    Date of Patent: March 24, 2009
    Assignee: BASF Aktiengesellschaft
    Inventors: Joerg Schneider, Guenter Scherr, Hans Schupp, Andreas Eichfelder, Alain Robert, Martin Reif
  • Publication number: 20080306261
    Abstract: Processes comprising: providing an alkanolic reaction mixture, the alkanolic reaction mixture comprising: at least one alkoxycarbonylaminotriazine; at least one carbonic ester; at least one C1-C13-alkanol, which alkanol may further comprise up to two ether-bound oxygen atoms and may further comprise a substituent selected from the group consisting of C1-C4-alkyls and hydroxyls; and at least one alkali metal alkoxide or alkaline earth metal alkoxide; and subjecting the alkanolic reaction mixture to extraction with a polar extractant such that at least a portion of polar/ionic components present in the reaction mixture are removed, wherein the polar extractant is less than entirely miscible with an organic phase of the reaction mixture, to form an alkanolic phase comprising the at least one alkoxycarbonylaminotriazine and a polar phase comprising the polar extractant and the portion of polar/ionic components; and wherein the extraction is carried out with one or more selected from the group consisting of mixer/
    Type: Application
    Filed: June 2, 2006
    Publication date: December 11, 2008
    Applicant: BASF Aktiengesellschaft
    Inventors: Jörg Schneider, Gunter Scherr, Rainer Erhardt, Andreas Eichfelder, Martin Reif, Stefan Hirsch, Georg Sieder, Thomas Holtmann, Jurgen Ciprian, Hermann Ascherl
  • Publication number: 20080267996
    Abstract: The present invention is directed to a method of inducing an immune response against a hepatitis B antigen (e.g., an antigen from a hepatitis B virus) in a mammal, which comprises administering to the mammal a priming composition (e.g., a DNA plasmid), comprising a source of one or more epitopes of the hepatitis B target antigen; and a boosting composition, comprising a source of one or more eptiopes of the hepatitis B target antigen (e.g., a non-replication or replication-impaired poxvirus such as MVA), wherein at least one epitope of the boosting composition is identical to an epitope of the priming composition. The present invention also is directed to a method of inducing an immune response against a hepatitis B antigen (e.g., an antigen from a hepatitis B virus) in a mammal, which comprises administering to the mammal a priming composition (e.g., a DNA plasmid), comprising a source of one or more epitopes of the hepatitis B target antigen.
    Type: Application
    Filed: November 20, 2007
    Publication date: October 30, 2008
    Applicant: Oxxon Therapeutics Ltd.
    Inventors: Joerg Schneider, James Chorlton, Gill Pearce, Nicola Jones, Dean Brown
  • Publication number: 20080207901
    Abstract: The invention relates to a process for preparing free-flowing, pulverulent alkoxycarbonylaminotriazine from an alkanolic reaction mixture which is obtained in the preparation of alkoxycarbonylaminotriazines and comprises at least one alkoxycarbonylaminotriazine, at least one cyclic and/or acyclic carbonic ester, at least one C1-C13-alkanol which optionally comprises one or two oxygen atoms in the form of ether bonds and is optionally substituted by C1-C4-alkyl and/or hydroxyl, and also at least one alkali metal or alkaline earth metal alkoxide, with or without melamine and with or without catalyst, by atomizing and drying the reaction mixture in a spray drier.
    Type: Application
    Filed: May 31, 2006
    Publication date: August 28, 2008
    Applicant: BASF Aktiengesellschaft
    Inventors: Joerg Schneider, Gunter Scherr, Rainer Erhardt, Andreas Eichfelder, Martin Reif, Stefan Hirsch, Georg Sieder, Thomas Holtmann, Jurgen Ciprian, Hermann Ascherl
  • Patent number: 7407661
    Abstract: New methods and reagents for vaccination are described which generate a CD8 T cell immune response against malarial and other antigens such as viral and tumour antigens. Novel vaccination regimes are described which employ a priming composition and a boosting composition, the boosting composition comprising a non-replicating or replication-impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition.
    Type: Grant
    Filed: April 28, 2004
    Date of Patent: August 5, 2008
    Assignee: Oxxon Therapeutics Limited
    Inventors: Andrew McMichael, Adrian V. S. Hill, Sarah C. Gilbert, Jörg Schneider, Magdalena Plebanski, Tomas Hanke, Geoffrey L. Smith, Tom Blanchard
  • Patent number: 7371856
    Abstract: A process is described for preparing alkoxycarbonylaminotriazines by reacting di- or triaminotriazines with dimethyl carbonate in the presence of an alcohol and of an alkali metal or alkaline earth metal methoxide base.
    Type: Grant
    Filed: December 12, 2006
    Date of Patent: May 13, 2008
    Assignee: BASF Aktiengesellschaft
    Inventors: Joerg Schneider, Guenter Scherr, Hans Schupp, Andreas Eichfelder, Alain Robert, Martin Reif
  • Publication number: 20070108029
    Abstract: A switch unit having a combined switch function and locking function for controlling industrial tools, both the locking function and the switch function being achieved magnetically.
    Type: Application
    Filed: August 6, 2004
    Publication date: May 17, 2007
    Inventors: Michael Wieler, Jürgen Kurz, Jörg Schneider
  • Patent number: 7169923
    Abstract: A process is described for preparing alkoxycarbonylaminotriazines by reacting di- or triaminotriazines with dimethyl carbonate in the presence of an alcohol and of an alkali metal or alkaline earth metal methoxide base.
    Type: Grant
    Filed: October 23, 2002
    Date of Patent: January 30, 2007
    Assignee: BASF Aktiengesellschaft
    Inventors: Joerg Schneider, Guenter Scherr, Hans Schupp, Andreas Eichfelder, Alain Robert, Martin Reif
  • Publication number: 20050175627
    Abstract: The invention relates to a recombinant polypeptide comprising amino acid sequence derived from at least one of an HIV gag gene product; an HIV pol gene product; or an HIV nef gene product, said sequence being mutated with respect to the natural sequence of said gene product, and said sequence maintaining each of the naturally occurring CD8+ T cell epitopes of said gene product as defined in p17 and p24 (gag), amino acids 1-440 of RT (pol) and nef shown in Example 8. Furthermore the invention relates to nucleic acids encoding same, and viral vectors encoding same, and to their use in medicine and in immunisation and vaccination.
    Type: Application
    Filed: December 9, 2004
    Publication date: August 11, 2005
    Applicant: Oxxon Therapeutics Ltd.
    Inventor: Joerg Schneider